Literature DB >> 14556808

Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis.

Aydin Arici1, Ioannis Matalliotakis, Anastasia Goumenou, Georgios Koumantakis, Simon Vassiliadis, Neal G Mahutte.   

Abstract

OBJECTIVE: Peritoneal fluid (PF) inflammatory factors may participate in the pathogenesis of endometriosis. The aim of this study was to investigate PF interleukin (IL)-18 levels in women with and without endometriosis.
DESIGN: Controlled clinical study.
SETTING: Women undergoing laparoscopy at a university hospital. PATIENT(S): Fifty women with previously untreated endometriosis, 8 women on GnRH agonists for endometriosis, and 18 control women with normal pelvic anatomy who were undergoing tubal ligation. INTERVENTION(S): Peritoneal fluid IL-18 levels as measured by ELISA. MAIN OUTCOME MEASURE(S): Peritoneal fluid IL-18 levels. RESULT(S): Peritoneal fluid IL-18 levels were significantly higher in women with previously untreated endometriosis (mean +/- SEM, 91.1 +/- 6.5 pg/mL) than in control women (59.4 +/- 2.0 pg/mL). Interestingly, women with superficial (100.0 +/- 10.2 pg/mL) and deep peritoneal implants (94.0 +/- 10.8 pg/mL) had significantly higher PF IL-18 levels than did women with endometriomas (57.8 +/- 1.8 pg/mL). Similarly, women with stage I-II endometriosis (97.3 +/- 8.0 pg/mL), but not women with stage III-IV endometriosis (74.9 +/- 9.9 pg/mL), had significantly higher PF IL-18 levels than did control women. Peritoneal fluid IL-18 levels were significantly higher in the luteal phase than in the follicular phase but did not discriminate between women with pelvic pain or infertility. CONCLUSION(S): Peritoneal fluid IL-18 is elevated in women with peritoneal, minimal- to mild-stage endometriosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556808     DOI: 10.1016/s0015-0282(03)01122-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

2.  Effect of simvastatin on baboon endometriosis.

Authors:  Hugh S Taylor; Myles Alderman Iii; Thomas M D'Hooghe; Asgerally T Fazleabas; Antoni J Duleba
Journal:  Biol Reprod       Date:  2017-07-01       Impact factor: 4.285

3.  Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis.

Authors:  Gengxiang Wu; N A Bersinger; M D Mueller; M von Wolff
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

4.  Extracts of Salvia miltiorrhiza Bunge on the cytokines of rat endometriosis models.

Authors:  Zan-Hua Zhou; Qing Weng; Jian-Hong Zhou; Jue Zhou
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

5.  Laparoscopy for the treatment of unexplained infertility.

Authors:  Yoshiaki Kanda; Mario Ikeda; Masahiko Ishikawa; Hideya Sakakibara; Fumiki Hirahara
Journal:  Reprod Med Biol       Date:  2006-03-01

Review 6.  A baboon model for endometriosis: implications for fertility.

Authors:  Julie M Hastings; Asgerally T Fazleabas
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

7.  Effect of Endometrioma cystectomy on cytokines of follicular fluid and IVF outcomes.

Authors:  Yu Liang; Xiaokui Yang; Yonglian Lan; Lingling Lei; Ying Li; Shuyu Wang
Journal:  J Ovarian Res       Date:  2019-10-21       Impact factor: 4.234

8.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13

9.  Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis.

Authors:  Toru Kato; Koubun Yasuda; Kazufumi Matsushita; Ken J Ishii; Seiichi Hirota; Tomohiro Yoshimoto; Hiroaki Shibahara
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.